| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/02/2001 | US20010011077 Secreted cysteine rich protein-6 (SCRP-6); polynucleotides and processes for producing polypeptides |
| 08/02/2001 | US20010010934 Polypeptides that regulate epithelial specific gene expression; hypoproliferative disorders; medical diagnosis |
| 08/02/2001 | US20010010929 Polynucleotides and polypeptides belonging to the uncoupling proteins family |
| 08/02/2001 | US20010010927 A method for screening candidate pesticides using a receptor that binds bacillus thuringiensis toxin |
| 08/02/2001 | US20010010926 New immunoregulatory protein lst-1 |
| 08/02/2001 | US20010010924 Inflammation, arthritis, septicemia, brain injury, autoimmune (inflammatory bowel, psoriasis)/bone/acute respiratory diseases, restenosis, AIDS, cancer (lympho-proliferative disorders, atheroscleosis, and Alzheimer's |
| 08/02/2001 | US20010010921 Cell-free and cell-based assays for screening drugs to treat eating disorders; dietetics; obesity, cachexia |
| 08/02/2001 | US20010010920 Complex of rapamycin-42 ester with dicarboxylic acid and fluorescein; antibody detection/generation; immunoglobulins; hybridomas; ring opening; precipitation |
| 08/02/2001 | US20010010913 Isolated polypeptide |
| 08/02/2001 | US20010010912 nrdF |
| 08/02/2001 | US20010010908 Reagents and methods useful for detecting diseases of the prostate |
| 08/02/2001 | US20010010904 Genetic engineering; overlapping Dna sequences |
| 08/02/2001 | US20010010901 Genetic engineering |
| 08/02/2001 | US20010010826 Contacting the site of wound with a matrix comprising gelatin and a nitric oxide scavanger to increase blood cirulation; nitric oxide scavanger are selected from L-arganine analog, dextran, heparin, cysteine and cystine |
| 08/02/2001 | US20010010815 Adeno-associated vector compositions for expression of factor VIII |
| 08/02/2001 | EP1144607A3 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 08/02/2001 | DE10011926A1 Genetisch veränderte Fibroblastenzellen Genetically modified fibroblast cells |
| 08/02/2001 | DE10002803A1 System zur internen qualitativen und quantitativen Validierung von Markerindices System of internal qualitative and quantitative validation of marker indices |
| 08/02/2001 | DE10001372A1 Anti-CD3-Einzelketten-Antikörper mit humanem Cmu3- und Cmu4- Domänen Anti-CD3 single-chain antibody with human Cmu3- and Cmu4- domains |
| 08/02/2001 | CA2398743A1 Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1 |
| 08/02/2001 | CA2398660A1 Human cyr61 |
| 08/02/2001 | CA2398564A1 Nuclear hormone receptors |
| 08/02/2001 | CA2398548A1 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 08/02/2001 | CA2398546A1 Methods and materials relating to cd84-like polypeptides and polynucleotides |
| 08/02/2001 | CA2398430A1 Human protein kinases and protein kinase-like enzymes |
| 08/02/2001 | CA2398401A1 Improved inhibition of graft versus host disease |
| 08/02/2001 | CA2398396A1 Methods and materials relating to transforming growth factor alpha-like polypeptides and polynucleotides |
| 08/02/2001 | CA2398284A1 Methods and compositions for generating human monoclonal antibodies |
| 08/02/2001 | CA2398273A1 Novel 'oxy' cms brassica napus plant corrected for chlorosis using hexaploid bridging material generated through protoplast fusion |
| 08/02/2001 | CA2398242A1 Fil-1 theta dnas and polypeptides |
| 08/02/2001 | CA2398227A1 17 human secreted proteins |
| 08/02/2001 | CA2398104A1 Polymorphisms in the human cyp2d6 gene promoter region and their use in diagnostic and therapeutic applications |
| 08/02/2001 | CA2398084A1 Three-dimensional matrix body, and device and method for measuring contractions of a cell tissue |
| 08/02/2001 | CA2398003A1 Phosphodiesterases |
| 08/02/2001 | CA2397532A1 Recombinant aav packaging systems |
| 08/02/2001 | CA2395857A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395832A1 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 08/02/2001 | CA2395811A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2395676A1 Nucleic acids, proteins, and antibodies |
| 08/02/2001 | CA2394332A1 Chimeric neuropeptide y receptors |
| 08/02/2001 | CA2393954A1 Nucleic acids, proteins, and antibodies |
| 08/01/2001 | EP1120466A2 Use of negative regulation elements for nerve-specific expression of transgenes |
| 08/01/2001 | EP1120462A1 Expansion of bone marrow stromal cells |
| 08/01/2001 | EP1119631A2 Transgene assay using stable agrobacterium rhizogenes transformation |
| 08/01/2001 | EP1119629A2 Oxidoreductase molecules |
| 08/01/2001 | EP1119623A1 Mage-a3 peptides presented by hla class ii molecules |
| 08/01/2001 | EP1119621A2 G-protein coupled receptor proteins |
| 08/01/2001 | EP1119620A2 Polynucleotides coding for secreted polypeptides. some having similarity to syncollin or claudin or cytokine. their therapeutic uses |
| 08/01/2001 | EP1119619A2 Nlk1 -interacting proteins |
| 08/01/2001 | EP1119617A2 Fusions of scaffold proteins with random peptide libraries |
| 08/01/2001 | EP1119616A2 Dna shuffling to produce nucleic acids for mycotoxin detoxification |
| 08/01/2001 | EP1119615A1 PRODUCTION OF ssDNA IN VIVO |
| 08/01/2001 | EP1119614A2 Protein tyrosine phosphatase-1b (ptp-1b) deficient mice and uses thereof |
| 08/01/2001 | EP1119612A1 Spodoptera frugiperda single cell suspension cell line in serum-free media, methods of producing and using |
| 08/01/2001 | EP1119611A1 Method for the treatment of chemonucleolysis |
| 08/01/2001 | EP1119584A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
| 08/01/2001 | EP1119582A2 Hypersensitive response elicitor fragments which are active but do not elicit a hypersensitive response |
| 08/01/2001 | EP1119581A1 METHODS OF INHIBITING SMOOTH MUSCLE CELL PROLIFERATION AND PREVENTING RESTENOSIS WITH A VECTOR EXPRESSING RB2/p130 |
| 08/01/2001 | EP1119579A1 Antisense modulation of bcl-x expression |
| 08/01/2001 | EP1119375A1 Methods and adjuvants for stimulating mucosal immunity |
| 08/01/2001 | EP1119365A1 Composition and method of using tumor cells |
| 08/01/2001 | EP1119349A2 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 08/01/2001 | EP1119253A1 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF |
| 08/01/2001 | EP0889959B1 Partial intron sequence of von hippel-lindau (vhl) disease gene and its use in diagnosis of disease |
| 08/01/2001 | EP0862629B1 Epithelial membrane protein-1 |
| 08/01/2001 | EP0698106B1 Marker gene |
| 08/01/2001 | EP0654532B1 Antimucoglycoprotein monoclonal antibody |
| 08/01/2001 | CN1306578A Transgenic plants with modified activity of plastidial ADP/ATP translocator |
| 08/01/2001 | CN1306577A Multiply-substituted protease variants |
| 08/01/2001 | CN1306575A Prodn of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
| 08/01/2001 | CN1306573A Novel human thrombopoietin mutein |
| 08/01/2001 | CN1306571A Methods for means for obtaining modified phenotypes |
| 08/01/2001 | CN1306542A Moraxella catharralis proteins |
| 08/01/2001 | CN1306437A Vaccine |
| 08/01/2001 | CN1306436A Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 08/01/2001 | CN1306390A Full term development of animals from enucleated oocytes reconstituted with adult somatic cell nuclei |
| 08/01/2001 | CN1306085A Application of substrate cell derived from fat tissue |
| 08/01/2001 | CN1306007A Dry cell factor |
| 08/01/2001 | CA2330023A1 Levodione reductase gene and use thereof |
| 07/31/2001 | US6269312 Apparatus and method for automated protein design |
| 07/31/2001 | US6268549 DNA sequence of a gene of hydroxy-phenyl pyruvate dioxygenase and production of plants containing a gene of hydroxy-phenyl pyruvate dioxygenase and which are tolerant to certain herbicides |
| 07/31/2001 | US6268547 Culturing immature plant embryos to form callus, transforming with dna coding for cyanamide hydratase, selecting for resistant cells by growing on media containing cyanamide, then regenerating transgenic plants |
| 07/31/2001 | US6268546 Ovary-tissue transcriptional factors |
| 07/31/2001 | US6268487 Purification of biologically active peptides from milk |
| 07/31/2001 | US6268486 Contacting mixture of polypeptide and impurities with specific monoclonal antibody so that binding occurs, desorbing polypeptide from antibody, and collecting polypeptide; immunoaffinity chromatography |
| 07/31/2001 | US6268482 Recombinant cytokine designated LERK-6 |
| 07/31/2001 | US6268478 From new world primate and having specific vitamin d binding activity of at least 17,588-fold greater than endogenous protein; therapy and diagnosis of osteoporosis and hypercalcemia; drug screening |
| 07/31/2001 | US6268477 Amino acid sequence; detection and treatment of atherosclerosis, rheumatoid arthritis, asthma, aids (acquired immune deficiency syndrome); viricides; antiinflammatory agents; antitumor agents; antiarthritic agents |
| 07/31/2001 | US6268348 That mimic the conformation necessary for recognition and docking of collagen binding species (such as cell surface receptors for collagen and fibronectin) and have the amino acid residues-ile-ala-folded in a beta-bend. |
| 07/31/2001 | US6268347 Alleviating neuropathic pain |
| 07/31/2001 | US6268334 Cells include cardiovascular cells, and the peptide may be delivered in a stent to treat or prevent restinosis. |
| 07/31/2001 | US6268328 Variant EGIII-like cellulase compositions |
| 07/31/2001 | US6268221 Drug screening for compound which binds to receptor by transforming host cell with recombinant expression contruct encoding the receptor, expressing in culture, and analyzing cells to determine binding |
| 07/31/2001 | US6268199 An infectious clone transfected with a recombinant nucleic acid of the porcine reproductive respiratory syndrome virus; vaccines |
| 07/31/2001 | US6268195 A genetically engineered plant pectin methyl esterase enyzme; used in the food industry as a thickening or gelling agent, such as in the preparation of jams. |
| 07/31/2001 | US6268188 Transaminases and aminotransferases |
| 07/31/2001 | US6268180 A nucleic acid encoding a polypeptide; production of biologically active interleukin |
| 07/31/2001 | US6268177 An isolated polynucleotide; therapy and treatment of streptococcal infections, pneumonia, meningitis, sinusitis, conjunctivitis; screening for antibiotics |
| 07/31/2001 | US6268151 Antisense modulation of macrophage migration inhibitory factor expression |
| 07/31/2001 | US6268138 Retroviral vector capable of transducing the aldehyde dehydrogenase-1 gene and making cells resistant to the chemotherapeutic agent cyclophosphamide and its derivatives and analogs |